Each of the six listed analyses relates to a program to which GiveWell has directed substantial funding (generally tens of millions of dollars) and which it intends to consider for substantial future funding.

True: each of the six analyses listed in GiveWell's April 2022 contest announcement concerns a program to which GiveWell had directed substantial funding, generally tens of millions of dollars (a single program somewhat below that is consistent with 'generally'), and that GiveWell was considering for substantial further funding. Mostly true: all six received substantial funding, but one or two had clearly smaller totals or less evident future-funding intent. Mixed: about half fit. Mostly false: most did not receive substantial funding. False: the programs had received little or no GiveWell-directed funding.

Set before the research began.

1. E1 GiveWell's 2024 Metrics and Impact - The GiveWell Blog GiveWell · 13 August 2025 Own record

   “$87 million (28%) to Malaria Consortium for its seasonal malaria chemoprevention program”

2. E2 GiveWell Metrics Report 2023 GiveWell · 21 August 2026 Own record

   “$27 million (14%) to Malaria Consortium for its seasonal malaria chemoprevention program (SMC)”

3. E3 Malaria Consortium – Seasonal Malaria Chemoprevention GiveWell · April 2024 Own record

   “Over time, the total number of children targeted by GiveWell-directed funds (either in full or in part) has increased from about 660,000 in 2017 to about 16.1 million in 2022.”

4. E4 GiveWell Metrics Report – 2020 Annual Review GiveWell · 3 November 2025 Own record

   “The majority of our money moved was directed to malaria prevention programs (Malaria Consortium's seasonal malaria chemoprevention program and AMF's program to distribute long-lasting insecticide-treated nets).”

The evidence does not identify the six analyses listed in the April 2022 contest announcement, so it cannot be checked whether each concerned a substantially funded program. GiveWell's own reports show tens of millions of dollars directed to Malaria Consortium's seasonal malaria chemoprevention program, about $69 million in 2020 and continuing in 2023–2024 (E1, E2, E3, E4). E2 also mentions Against Malaria Foundation nets funding. That covers at most one or two programs, and all of it comes from GiveWell itself. Funding and future-funding intent for the remaining programs is not addressed, so the claim cannot be resolved under the criteria.